ScoreHaematology

FLIPI and FLIPI-2 in follicular lymphoma

International prognostic indices for follicular lymphoma: FLIPI (overall survival) and FLIPI-2 (progression-free survival).

Updated 31 October 2026

When to use it

Patients with follicular lymphoma at diagnosis, to estimate prognosis and stratify trials; they do not decide alone when to treat.

What it needs

  • Age > 60 yearsYes or no
  • Haemoglobin < 12 g/dLYes or no
  • Ann Arbor stage III–IVYes or no
  • More than 4 nodal areas involvedYes or no
  • LDH above the upper limit of normalYes or no
  • β2-microglobulin above the upper limit of normalYes or no
  • Longest diameter of the largest node > 6 cmYes or no
  • Bone marrow involvementYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

FLIPI
ResultInterpretation
≤ 1Low risk (0–1 factors)
2Intermediate risk (2 factors)
≥ 3High risk (≥ 3 factors)

In the app it also calculates: FLIPI-2.

Practical tip

The decision to treat rests on tumour burden and symptoms (e.g. GELF criteria), not on FLIPI.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top